---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-030677"
form_type: "8-K"
ticker: "FUL"
cik: "0000039368"
company_name: "FULLER H B CO"
filed_at: "2025-10-08T23:59:59+00:00"
generated_at: "2026-05-17T04:22:31.345533+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# H.B. Fuller appoints former J&J MedTech executive Celine Martin to board

## Summary
- Celine Martin, 51, elected as Class III director effective Dec. 1, 2025, serving on Audit and Compensation Committees.
- Martin most recently served as Company Group Chairman, Cardiovascular & Specialty Solutions at Johnson & Johnson MedTech (2022–2025).
- Appointment supports H.B. Fuller's strategic expansion into high-margin medical adhesives and goal of >20% EBITDA margin.
- Board size increases to nine directors, eight independent; Martin receives $100K cash retainer and 1,300 RSUs.

## SEC filing metadata
- accession: 0001437749-25-030677
- form_type: 8-K
- ticker: FUL
- cik: 0000039368
- company_name: FULLER H B CO
- filed_at: 2025-10-08T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/39368/000143774925030677/0001437749-25-030677-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/39368/000143774925030677/ful20251007_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-030677
- JSON: https://secwatch.observer/filing/0001437749-25-030677.json
- Plain text: https://secwatch.observer/filing/0001437749-25-030677.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.